Stockscreener 앱 받기
79.67
0.36%
-0.29
시간 외 거래:
79.74
0.07
+0.09%
전일 마감가:
$79.96
열려 있는:
$79.9
하루 거래량:
11.77M
Relative Volume:
0.91
시가총액:
$199.00B
수익:
$63.43B
순이익/손실:
$16.42B
주가수익비율:
12.28
EPS:
6.49
순현금흐름:
$14.72B
1주 성능:
-1.81%
1개월 성능:
-8.81%
6개월 성능:
-13.69%
1년 성능:
-30.70%
1일 변동 폭
$79.33
$80.11
1주일 범위
$79.33
$82.40
52주 변동 폭
$73.31
$116.02
머크앤드컴퍼니 Stock (MRK) Company Profile
명칭
Merck Co Inc
전화
908-740-4000
주소
126 EAST LINCOLN AVENUE, RAHWAY, NJ
MRK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
79.67 | 199.72B | 63.43B | 16.42B | 14.72B | 6.49 |
|
LLY
Lilly Eli Co
|
741.85 | 669.64B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
176.69 | 425.26B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
219.99 | 393.25B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
123.00 | 237.76B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
NVO
Novo Nordisk Adr
|
58.74 | 264.56B | 45.44B | 16.18B | 9.21B | 3.634 |
머크앤드컴퍼니 Stock (MRK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-17 | 다운그레이드 | Berenberg | Buy → Hold |
| 2025-05-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-04-22 | 개시 | Cantor Fitzgerald | Neutral |
| 2025-02-18 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-02-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-01-08 | 다운그레이드 | Truist | Buy → Hold |
| 2024-12-20 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | 재개 | BofA Securities | Buy |
| 2024-12-04 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-11 | 다운그레이드 | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-03-11 | 다운그레이드 | Societe Generale | Hold → Sell |
| 2024-01-04 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Buy |
| 2023-10-27 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | 업그레이드 | UBS | Neutral → Buy |
| 2023-07-14 | 개시 | HSBC Securities | Hold |
| 2023-04-13 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-03-28 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2023-03-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | 개시 | Jefferies | Buy |
| 2023-02-22 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-10-10 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-09-14 | 업그레이드 | Berenberg | Hold → Buy |
| 2022-07-06 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | 재개 | SVB Leerink | Outperform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-12-17 | 개시 | Goldman | Buy |
| 2021-12-16 | 개시 | Daiwa Securities | Neutral |
| 2021-12-13 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-12-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-11-29 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-11-01 | 업그레이드 | Argus | Hold → Buy |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-20 | 다운그레이드 | Argus | Buy → Hold |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | 재개 | Bernstein | Outperform |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-08-03 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-06-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-01-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-16 | 개시 | SVB Leerink | Outperform |
| 2019-07-03 | 개시 | Mizuho | Buy |
| 2019-05-28 | 개시 | Goldman | Neutral |
| 2019-05-13 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | 재확인 | Citigroup | Buy |
| 2018-10-09 | 재개 | Guggenheim | Buy |
| 2018-04-23 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-04-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-03-12 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-02-07 | 재확인 | Morgan Stanley | Equal-Weight |
| 2018-01-16 | 업그레이드 | SunTrust | Hold → Buy |
모두보기
머크앤드컴퍼니 주식(MRK)의 최신 뉴스
Shareholders of Verona Pharma Approve Proposed Acquisition by Merck - The Manila Times
Shareholders of Verona Pharma Approve Proposed Acquisition by Merck - Benzinga
Pneumococcal Vaccine Market Opportunities and Strategies to 2034 - GlobeNewswire Inc.
Foster Victor Wealth Advisors LLC Has $9.83 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Public Employees Retirement System of Ohio Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
IMS Capital Management Buys New Shares in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Holdings Raised by Northside Capital Management LLC - MarketBeat
Ballentine Partners LLC Has $3.86 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Top Companies in Precision Swine Farming MarketMerck & Co., - openPR.com
Maseco LLP Takes Position in Merck & Co., Inc. $MRK - MarketBeat
CCM Investment Advisers LLC Buys 22,535 Shares of Merck & Co., Inc. $MRK - MarketBeat
Fifth Third Bancorp Has $49.32 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Perpetual Ltd Has $65.24 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Viking Fund Management LLC Cuts Stake in Merck & Co., Inc. $MRK - MarketBeat
Wright Investors Service Inc. Grows Holdings in Merck & Co., Inc. $MRK - MarketBeat
Exchange Traded Concepts LLC Increases Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by BDF Gestion - MarketBeat
Merck & Co., Inc. (MRK) Received FDA Approval For Keytruda Qlex, Cutting Infusion Time to 2 Minutes - Yahoo Finance
Farther Finance Advisors LLC Purchases 43,507 Shares of Merck & Co., Inc. $MRK - MarketBeat
Avanza Fonder AB Has $19.36 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Kaufman Rossin Wealth LLC Buys 3,410 Shares of Merck & Co., Inc. $MRK - MarketBeat
Sowell Financial Services LLC Buys 5,704 Shares of Merck & Co., Inc. $MRK - MarketBeat
YHB Investment Advisors Inc. Decreases Position in Merck & Co., Inc. $MRK - MarketBeat
UMB Bank n.a. Has $10.18 Million Position in Merck & Co., Inc. $MRK - MarketBeat
CX Institutional Decreases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Hall Laurie J Trustee Cuts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Compagnie Lombard Odier SCmA Has $54.96 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Variational AI inks drug discovery deal with Merck worth up to $349-million - The Globe and Mail
Assenagon Asset Management S.A. Acquires 1,391,088 Shares of Merck & Co., Inc. $MRK - MarketBeat
Baugh & Associates LLC Raises Stake in Merck & Co., Inc. $MRK - MarketBeat
Cardinal Capital Management Grows Position in Merck & Co., Inc. $MRK - MarketBeat
Occidental Asset Management LLC Has $3.83 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by CHICAGO TRUST Co NA - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by ARS Wealth Advisors Group LLC - MarketBeat
Park Avenue Securities LLC Buys New Stake in Merck & Co., Inc. $MRK - MarketBeat
Marshall Financial Group LLC Buys 6,058 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Redhawk Wealth Advisors Inc. - MarketBeat
IFM Investors Pty Ltd Buys 19,380 Shares of Merck & Co., Inc. $MRK - MarketBeat
Security National Bank Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Holdings Lifted by Ferguson Wellman Capital Management Inc. - MarketBeat
FDA Grants Breakthrough Therapy Designation to Merck & Co., Inc. (MRK)’s Raludotatug Deruxtecan for Platinum-Resistant Ovarian - Yahoo Finance
FDA Clears Merck's One-Minute Cancer Shot - Benzinga
Golden State Equity Partners Sells 13,135 Shares of Merck & Co., Inc. $MRK - MarketBeat
6,450 Shares in Merck & Co., Inc. $MRK Bought by Financial Harvest LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by LaFleur & Godfrey LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by GAMMA Investing LLC - MarketBeat
Mn Services Vermogensbeheer B.V. Has $74.47 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck: Undervalued Pharma Stock With Defensive Approach And Compelling Dividend Yield - Seeking Alpha
Rockland Trust Co. Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Procyon Advisors LLC Has $1.78 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Toth Financial Advisory Corp Sells 3,215 Shares of Merck & Co., Inc. $MRK - MarketBeat
머크앤드컴퍼니 (MRK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.34%
0.15%
자본화:
|
볼륨(24시간):